Literature DB >> 2002063

Structure of the human MDR3 gene and physical mapping of the human MDR locus.

C R Lincke1, J J Smit, T van der Velde-Koerts, P Borst.   

Abstract

Two genes, MDR1 and MDR3, constitute the human P-glycoprotein gene family. To examine the evolutionary relationship between the three known classes of mammalian P-glycoprotein genes, we have cloned the MDR3 gene and compared its structure with that of the human MDR1 and the mouse mdr1 (mdr1b) genes analyzed by other groups. The MDR3 gene contains 28 exons and 27 of these contain coding sequences for the two homologous halves of the protein that correlate with functional domains. This structure is virtually identical to that of the human MDR1 gene and the mouse mdr1 (mdr1b) gene, indicating that the exon/intron structure was fixed before the duplication events that generated different classes of P-glycoproteins, but after the P-glycoproteins diverged from related genes, like the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which has an entirely different exon/intron structure. The four alternatively spliced transcripts of the MDR3 gene arise from alternative splicing of exons 23 and 26. Our analysis of DNA clones covering about 120 kilobases (kb) of the human MDR locus, including the entire MDR3 gene (74 kb) and the intergenic region between both genes (34 kb), combined with pulsed-field gel electrophoresis data shows that the human MDR locus covers about 230 kb. In contrast to the mouse mdr genes, both human genes are transcribed in the same direction (MDR3 located downstream of MDR1). The CpG-rich sequences marking the 5' ends of both genes are hypomethylated to different extents in different cell lines. Hypomethylation roughly correlates with transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002063

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  P-glycoprotein structure and evolutionary homologies.

Authors:  I Bosch; J M Croop
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.

Authors:  Eric Pasmant; Philippe Goussard; Laetitia Baranes; Ingrid Laurendeau; Samuel Quentin; Philippe Ponsot; Yann Consigny; Olivier Farges; Bertrand Condat; Dominique Vidaud; Michel Vidaud; Jian-Min Chen; Béatrice Parfait
Journal:  Eur J Hum Genet       Date:  2011-10-12       Impact factor: 4.246

Review 3.  P-glycoprotein structure and evolutionary homologies.

Authors:  J M Croop
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 4.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

5.  Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.

Authors:  Elena V Batrakova; David L Kelly; Shu Li; Yili Li; Zhihui Yang; Li Xiao; Daria Y Alakhova; Simon Sherman; Valery Yu Alakhov; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2006 Mar-Apr       Impact factor: 4.939

6.  Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB carcinoma cells.

Authors:  P V Schoenlein; D W Shen; J T Barrett; I Pastan; M M Gottesman
Journal:  Mol Biol Cell       Date:  1992-05       Impact factor: 4.138

Review 7.  Drug resistance in brain tumors.

Authors:  L G Feun; N Savaraj; H J Landy
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Peripheral neuropathy in mice transgenic for a human MDR3 P-glycoprotein mini-gene.

Authors:  J J Smit; F Baas; J E Hoogendijk; G H Jansen; M A van der Valk; A H Schinkel; A J Berns; D Acton; K Nooter; H Burger; S J Smith; P Borst
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

9.  MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients.

Authors:  C Ramachandran; A Sauerteig; K S Sridhar; R J Thurer; A Krishan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 10.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.